Host immune response and pathological expression in malaria: possible implications for malaria vaccines.
D000818:Animals; D000917:Antibody Formation; D000953:Antigens, Protozoan / Q000276:immunology*; D001927:Brain Diseases / Q000188:drug therapy / Q000276:immunology; D003524:Cyclosporins / Q000627:therapeutic use; D000939:Epitopes / Q000276:immunology; D006801:Humans; D008288:Malaria / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D010961:Plasmodium / Q000276:immunology*; D010962:Plasmodium berghei / Q000276:immunology; D010963:Plasmodium falciparum / Q000276:immunology; D013921:Thrombocytopenia / Q000209:etiology; D014612:Vaccines / Q000276:immunology*
D000953:Antigens, Protozoan; D003524:Cyclosporins; D000939:Epitopes; D014612:Vaccines